New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 21, 2014
10:02 EDTTCPI, REGN, SGGH, MTLS, XNET, STAG, IMPR, FNF, ADPT, FAF, ECR, LCUT, GPRO, AMPHOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Adeptus Health (ADPT) initiated with a Buy at Dougherty... Amphastar (AMPH) initiated with a Buy at Jefferies... Eclipse Resources (ECR) initiated with a Neutral at SunTrust... Fidelity National (FNF) initiated with a Buy at SunTrust... First American (FAF) initiated with a Buy at SunTrust... GoPro (GPRO) initiated with a Hold at Stifel... Imprivata (IMPR) initiated with an Outperform at Wells Fargo... Lifetime Brands (LCUT) initiated with a Buy at Sidoti... Materialise (MTLS) initiated with a Buy at BB&T... Regeneron (REGN) initiated with a Buy at Argus... STAG Industrial (STAG) initiated with a Buy at Sandler O'Neill... Signature Group (SGGH) initiated with a Buy at B. Riley... TCP International (TCPI) initiated with a Buy at Canaccord... Tessera (TSRA) initiated with a Buy at Craig-Hallum... Xunlei (XNET) initiated with a Perform at Oppenheimer.
News For ADPT;AMPH;ECR;FNF;GPRO;FAF;IMPR;LCUT;MTLS;REGN;STAG;SGGH;TCPI;XNET From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
March 24, 2015
12:59 EDTGPROGoPro Channel launches on premium video service Vessel
Subscribe for More Information
07:34 EDTMTLSCanaccord to hold a conference
Musculoskeletal Conference is being held in Las Vegas on March 24.
05:59 EDTGPROGoPro implied volatility of 50 at lower end of index mean range
March 23, 2015
16:20 EDTLCUTMill Road Capital II reports 7.2% stake in Lifetime Brands
Subscribe for More Information
13:41 EDTGPROGoPro moves sharply higher on low volume, levels to watch
Subscribe for More Information
10:08 EDTFNFHigh option volume stocks
Subscribe for More Information
09:16 EDTGPROeBay adds two independent directors in preparation for PayPal separation
eBay (EBAY) announced the appointment of two new independent directors in anticipation of completing its previously announced separation of eBay and PayPal. Tony Bates, President of GoPro (GPRO), and Gail McGovern, President and CEO of the American Red Cross, have been appointed to eBay Inc.’s board of directors. eBay also announced that current directors William C. Ford and Richard T. Schlosberg, who have served for 10 years and 11 years, respectively, have advised the company that they do not plan to stand for re-election to the board at the 2015 Annual Meeting. With the appointment of Bates and McGovern, eBay's board currently is comprised of 17 directors, 15 of whom are independent. Following the company’s Annual Meeting, which will be held on May 1, eBay’s board will be comprised of 15 directors, 13 of whom will be independent. Additionally, eBay announced that Jonathan Christodoro has been elected to its board as part of the previously announced standstill agreement with Carl Icahn, the company’s largest active shareholder.
08:13 EDTFNFFidelity National announces preliminary results of dutch auction tender offer
Subscribe for More Information
07:17 EDTREGNAmerican Academy of Dermatology to hold annual meeting
73rd Annual Meeting of AAD is being held in San Francisco on March 20-24.
March 20, 2015
10:00 EDTREGNOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:05 EDTREGNRegeneron initiated with a Buy at Chardan
Subscribe for More Information
March 18, 2015
09:20 EDTGPROComplaints against police fell after body cameras added, Channel 10 says
Subscribe for More Information
06:03 EDTGPROStocks with implied volatility below IV index mean; CYBR GRPO
Subscribe for More Information
March 17, 2015
11:36 EDTGPROGoPro Channel app tops 1M downloads on Xbox platform
GoPro (GPRO) announced that The GoPro Channel app has been downloaded over 1M times on the Xbox video game and entertainment system from Microsoft (MSFT). Additionally, users are watching an average of 25 minutes of GoPro videos during each viewing session. The GoPro Channel allows Xbox members worldwide to stream GoPro content on-demand, share favorite videos, and purchase cameras and accessories directly through the console.
March 16, 2015
11:38 EDTMTLSMaterialise management to meet with Pacific Crest
Subscribe for More Information
10:35 EDTGPROGoPro falls, levels to watch
Subscribe for More Information
08:23 EDTREGNPCSK9 data continues to impress, says Leerink
Subscribe for More Information
07:16 EDTREGNRegeneron Sanofi dupilumab drug can generate $6B+ in revenue, says Bernstein
Bernstein believes that dupilumab, a drug made by Regeneron and Sanofi, has shown strong efficacy in patients with severe atopic dermatitis. The firm notes that the drug is currently in pivotal trials involving patients with severe levels of other common diseases. The firm thinks the drug can generate $1.5B of revenue by 2018 and $3.8B by 2020. Bernstein keeps a $500 price target and Outperform rating on Regeneron.
06:40 EDTREGNPCSK9 studies show potential improvement in heart health, WSJ says
Subscribe for More Information
March 15, 2015
13:04 EDTREGNSanofi, Regeneron announce publication of results of ODYSSEY long term trial
Sanofi (SNY) and Regeneron Pharmaceuticals (REGN) today announced that 18-month results of a Phase 3 trial of Praluent, alirocumab, an investigational therapy, involving 2,341 high risk patients with hypercholesterolemia were published online in The New England Journal of Medicine. In the ODYSSEY LONG TERM trial, Praluent 150 mg every two weeks reduced low-density lipoprotein cholesterol by an additional 62% at week 24 when compared to placebo, the primary efficacy endpoint of the study, with consistent LDL-C lowering maintained over 78 weeks."These results demonstrated the durable efficacy for Praluent when added to maximally-tolerated statin therapy and further reinforce its generally consistent safety profile," said Jennifer Robinson, M.D., M.P.H., Director of the Prevention Intervention Center, Professor, Departments of Epidemiology & Medicine, College of Public Health at the University of Iowa. "Additionally, the post hoc analysis of major cardiovascular events represents an important finding for Praluent -- we look forward to results from the ongoing ODYSSEY OUTCOMES trial, which is prospectively evaluating the potential of Praluent to reduce cardiovascular events."
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use